VF Corp. (VFC) Pops 3.49% for February 15

Equities Staff |

One of the S&P 500’s big winners for Monday February 15 was VF Corp. (VFC) as the company’s stock climbed 3.49% to $58.79 on volume of 2.41 million shares.

The stock opened at $57.55 and saw an intraday low of $57.19 and an intraday high of $58.86. All told, the day saw a per-share gain of $1.98. The stock’s average daily volume of 2.89 million and 426.31 million shares outstanding. VF Corp. now has a 50-day SMA is $60.42 and 200-day SMA is $67.67, and it has a 52-week high of $77.83 and a 52-week low of $52.21.

VF Corp is an apparel and footwear company. It designs and manufactures or sources from independent contractors a variety of apparel and footwear for all ages.

Based out of Greensboro, NC, VF Corp. has 59,000 employees and, after today’s trading, reached a market cap of $25.06 billion. The stock’s P/E Ratio is 23.5. Its P/S ratio is 2.7, P/B ratio is 4.67, and P/FCF ratio is -23.5.

For a complete fundamental analysis analysis of VF Corp., check out Equities.com’s Stock Valuation Analysis report for VFC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…